A tumor metabolome panel identifies altered cell states that lead to drug tolerance.

Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.

Researchers Jason Gill and Paul Turner will discuss their work on bacteriophage therapy to treat drug resistant bacterial infections.

Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!

New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.

The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.